Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SGN-BB228 |
Trade Name | |
Synonyms | SGN BB228|SGNBB228|PRS 346|PRS-346|PRS346 |
Drug Descriptions |
SGN-BB228 comprises an anti-CD228 antibody linked to anti-calin proteins targeting TNFRSF9 (4-1BB), which potentially leads to enhanced antitumor immune response (Journal for ImmunoTherapy of Cancer 2022;10). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C192209 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
SGN-BB228 | SGN-BB228 | 0 | 1 |